Text Mining And Machine Reading: The Answer To Pharma's R&D Data Mountain?
Executive Summary
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
You may also be interested in...
Adherence Issues Add Weight To Digital Trials Push
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
Appointments: Five Prime, Depomed, Gilead, Arix Bioscience and Corbus
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.
Back To The Drawing Board For Double Bond's Temodex Mission
A failed deal has left Double Bond Pharmaceuticals again on the search for a partner in order to take its lead products forward. CEO Igor Lokot shares next steps and partnering plans.